CL2019000845A1 - Formulación probiótica que comprende cepas weissella viridescens aisladas desde helix aspersa müller y su uso para la prevención y tratamiento coadyuvante del acné vulgar - Google Patents

Formulación probiótica que comprende cepas weissella viridescens aisladas desde helix aspersa müller y su uso para la prevención y tratamiento coadyuvante del acné vulgar

Info

Publication number
CL2019000845A1
CL2019000845A1 CL2019000845A CL2019000845A CL2019000845A1 CL 2019000845 A1 CL2019000845 A1 CL 2019000845A1 CL 2019000845 A CL2019000845 A CL 2019000845A CL 2019000845 A CL2019000845 A CL 2019000845A CL 2019000845 A1 CL2019000845 A1 CL 2019000845A1
Authority
CL
Chile
Prior art keywords
prevention
strains
isolated
acne vulgaris
adjunctive treatment
Prior art date
Application number
CL2019000845A
Other languages
English (en)
Inventor
Monje Marcela Maritza Espinoza
Cancino Apolinaria Del Rosario Garcia
Zamorano Cristian Felipe Gutierrez
Original Assignee
Monje Marcela Maritza Espinoza
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Monje Marcela Maritza Espinoza filed Critical Monje Marcela Maritza Espinoza
Priority to CL2019000845A priority Critical patent/CL2019000845A1/es
Publication of CL2019000845A1 publication Critical patent/CL2019000845A1/es
Priority to PCT/CL2019/050126 priority patent/WO2020198895A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • C12N1/205—Bacterial isolates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/747—Lactobacilli, e.g. L. acidophilus or L. brevis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/10—Anti-acne agents
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00—Microorganisms ; Processes using microorganisms
    • C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00—Microorganisms ; Processes using microorganisms
    • C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
    • C12R2001/225—Lactobacillus

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Genetics & Genomics (AREA)
  • Mycology (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Biotechnology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Virology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Dermatology (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Cosmetics (AREA)

Abstract

Esta tecnología comprende 2 cepas aisladas desde Helix aspersa Müller las que se encuentran depositadas en la Colección Chilena de Recursos Genéticos Microbianos (CChRGM) bajo el código de acceso RGM 2678 y RGM 2679. También se presenta una formulación tópica que las contiene y su uso como probióticos para la prevención y tratamiento coadyuvante del acné vulgar.
CL2019000845A 2019-03-29 2019-03-29 Formulación probiótica que comprende cepas weissella viridescens aisladas desde helix aspersa müller y su uso para la prevención y tratamiento coadyuvante del acné vulgar CL2019000845A1 (es)

Priority Applications (2)

Application Number Priority Date Filing Date Title
CL2019000845A CL2019000845A1 (es) 2019-03-29 2019-03-29 Formulación probiótica que comprende cepas weissella viridescens aisladas desde helix aspersa müller y su uso para la prevención y tratamiento coadyuvante del acné vulgar
PCT/CL2019/050126 WO2020198895A1 (es) 2019-03-29 2019-12-02 Formulación probiótica que comprende cepas aisladas desde helix aspersa müller y su uso para la prevención y tratamiento coadyuvante del acné vulgar

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CL2019000845A CL2019000845A1 (es) 2019-03-29 2019-03-29 Formulación probiótica que comprende cepas weissella viridescens aisladas desde helix aspersa müller y su uso para la prevención y tratamiento coadyuvante del acné vulgar

Publications (1)

Publication Number Publication Date
CL2019000845A1 true CL2019000845A1 (es) 2019-08-30

Family

ID=67769699

Family Applications (1)

Application Number Title Priority Date Filing Date
CL2019000845A CL2019000845A1 (es) 2019-03-29 2019-03-29 Formulación probiótica que comprende cepas weissella viridescens aisladas desde helix aspersa müller y su uso para la prevención y tratamiento coadyuvante del acné vulgar

Country Status (2)

Country Link
CL (1) CL2019000845A1 (es)
WO (1) WO2020198895A1 (es)

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3795011B2 (ja) * 2002-12-16 2006-07-12 株式会社ヤクルト本社 保湿剤及びこれを含有する化粧料
CA2557834C (en) * 2004-03-04 2012-05-22 E-L Management Corporation Skin treatment method with lactobacillus extract
FR2938437B1 (fr) * 2008-11-19 2020-03-27 Société des Produits Nestlé S.A. Utilisation cosmetique de microorganisme pour le traitement des peaux grasses
KR101258692B1 (ko) * 2010-10-14 2013-04-29 대한민국 항생제 저항성 포도상구균(ｍｒｓａ)억제 유산균 바이셀라 비리데센스
GB201206599D0 (en) * 2012-04-13 2012-05-30 Univ Manchester Probiotic bacteria
CN104644840A (zh) * 2015-02-10 2015-05-27 济南康众医药科技开发有限公司 一种治疗痤疮的药物组合物的制备方法

Also Published As

Publication number Publication date
WO2020198895A1 (es) 2020-10-08

Similar Documents

Publication Publication Date Title
AR106768A1 (es) Composiciones que comprenden cepas bacterianas
Murugesan et al. Phytochemical screening and Antimicrobial activity of the leaves of Memecylon umbellatum burm. F.
BR112022009600A2 (pt) Paenibacillus peoriae fixador de nitrogênio isolado, cultura biologicamente pura de um paenibacillus peoriae fixador de nitrogênio, uso de um ou mais paenibacillus peoriae fixadores de nitrogênio e do consórcio microbiano sintético, método, composição inoculante e de sementes de ocorrência não natural, e, consórcio microbiano sintético
AR079499A1 (es) Uso combinado de las proteinas cry1da y cry1fa para el manejo de la resistencia de insectos
Ma et al. Endophytic pestalotiod taxa in Dendrobium orchids
ES2531193T3 (es) Cepas de levadura y métodos de utilización de las mismas
BR112017014052A2 (pt) composições e métodos para uso de inseticida com d747 de bacillus sp
BR112017000885A2 (pt) clonostachys rosea inoculadas em materiais vegetais com fungicidas e adjuvantes.
CO2020007601A2 (es) Cepa vacunal de brucella modificada para el tratamiento de brucelosis
CL2019000845A1 (es) Formulación probiótica que comprende cepas weissella viridescens aisladas desde helix aspersa müller y su uso para la prevención y tratamiento coadyuvante del acné vulgar
PE20200295A1 (es) Mitocetoscinas: agentes terapeuticos basados en mitocondrias que fijan como objetivo el metabolismo de cetonas en celulas cancerosas
CL2023003240A1 (es) Cepas bacterianas con actividad fungicida, composiciones que las comprenden y uso de las mismas
ES2486166A1 (es) Hongos como agentes de control biológico
Odyuo et al. Rohdea extrorsandra (Asparagaceae), a new species from north-eastern India
Sasmakov et al. In vitro screening of the cytotoxic, antibacterial and antioxidant activities of some Uzbek plants used in folk medicine
Arora et al. Antimicrobial potential of Moringa oleifera seed coat and its bioactive phytoconstituents
Wetschnig et al. Massonia saniensis (Asparagaceae, Scilloideae), a new species from Lesotho, southern Africa
AR113143A1 (es) Cepa de tolypocladium album y su uso como plaguicida biológico
CL2017003480A1 (es) Mezcla de biocontroladores fúngicos para el control de hongos causales del brazo muerto de la vid
AR112145A1 (es) Composiciones que comprenden cepas bacterianas
Atcı et al. Ranunculus sericeus Banks & Sol. Extract Fractions Possess Antibacterial and Antifungal Activity
MX2018007002A (es) Composiciones equibioticas utiles en la reversion de la resistencia microbiana a los antibioticos.
Budanova USE OF BIOLOGICALLY ACTIVE COMPOUNDS OF BLUE-GREEN ALGAE SPIRULINA PLATENSIS IN MEDICINE AND PHARMACY
Belaidi et al. Antagonistic activity of three species of bacteria against Fusarium oxysporum f. sp. albedinis, the causal agent of Bayoud disease on date palm (Phoenix dactylifera L.).
Arslan et al. Antimicrobial Activity of Plantago major Grown in Kahramanmaraş Against Bacteria Causing Hospital Infections